Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (391-400 of 655) with videos related to

Pageof 66
Sort By:
Plos Neglected Tropical Diseases|April 4, 2022
Assessment of environmental contamination with soil-transmitted helminths life stages at school compounds, households and open markets in Jimma Town, EthiopiaBamlaku Tadege, Zeleke Mekonnen, Daniel Dana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag/Rij ratsJ H Schellens, W Van de Vrie, W J Loos, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupD J Wagener, R Somers, A Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies GroupP Schöffski, G Catimel, A S Planting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: an EORTC-ECSG phase II clinical studyT Gamucci, R Paridaens, B Heinrich, et al.
Acta Tropica|March 23, 2016
Malaria and HIV among pediatric inpatients in two Tanzanian referral hospitals: A prospective studyLuke R Smart, Neema Orgenes, Humphrey D Mazigo, et al.
British Journal of Cancer|July 29, 1999
A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervixR de Wit, J van der Zee, M E van der Burg, et al.
Neurology|March 4, 1998
Lhermitte's sign following chemotherapy with docetaxelM J van den Bent, P H Hilkens, P A Sillevis Smitt, et al.
Pageof 66

Showing results (391-400 of 655) with videos related to

Sort By:
Pageof 66
Plos Neglected Tropical Diseases|April 4, 2022
Assessment of environmental contamination with soil-transmitted helminths life stages at school compounds, households and open markets in Jimma Town, EthiopiaBamlaku Tadege, Zeleke Mekonnen, Daniel Dana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag/Rij ratsJ H Schellens, W Van de Vrie, W J Loos, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupD J Wagener, R Somers, A Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies GroupP Schöffski, G Catimel, A S Planting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: an EORTC-ECSG phase II clinical studyT Gamucci, R Paridaens, B Heinrich, et al.
Acta Tropica|March 23, 2016
Malaria and HIV among pediatric inpatients in two Tanzanian referral hospitals: A prospective studyLuke R Smart, Neema Orgenes, Humphrey D Mazigo, et al.
British Journal of Cancer|July 29, 1999
A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervixR de Wit, J van der Zee, M E van der Burg, et al.
Neurology|March 4, 1998
Lhermitte's sign following chemotherapy with docetaxelM J van den Bent, P H Hilkens, P A Sillevis Smitt, et al.
Pageof 66